Myovant Sciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYOV and other ETFs, options, and stocks.

About MYOV

Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. 

CEO
David C. Marek
CEODavid C. Marek
Employees
579
Employees579
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2016
Founded2016
Employees
579
Employees579

MYOV Key Statistics

Market cap
1.74B
Market cap1.74B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
631.82K
Average volume631.82K
High today
$18.29
High today$18.29
Low today
$17.20
Low today$17.20
Open price
$17.20
Open price$17.20
Volume
558.08K
Volume558.08K
52 Week high
$24.09
52 Week high$24.09
52 Week low
$7.67
52 Week low$7.67

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

MYOV Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
per share
Estimated per share
Actual
Actual
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.